Menu
EPIDEMOLOGY
Distribution patterns of COVID19EPIDEMOLOGY
 |
Visual Data Analysis and Simulation Prediction for COVID-19 |
|---|
|
A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person... |
|---|
|
Advances on presymptomatic or asymptomatic carrier transmission of COVID-19 |
|---|
|
Analysis of COVID-19 infection spread in Japan based on stochastic transition model |
|---|
|
Analysis on epidemic situation and spatiotemporal changes of COVID-19 in Anhui |
|---|
|
Anesthesia Procedure of Emergency Operation for Patients with Suspected or Confirmed COVID-19 |
|---|
|
Application of the ARIMA model on the COVID-2019 epidemic dataset |
|---|
|
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
|---|
|
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China... |
|---|
|
Characteristics of COVID-19 infection in Beijing |
|---|
Korea
|
Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Republic of Korea |
|---|
|
Prediction of COVID-19 Spreading Profiles in South Korea, Italy and Iran by Data-Driven Coding |
|---|
Italy
|
2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological... |
|---|
|
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy |
|---|
|
Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During... |
|---|
|
Prediction of COVID-19 Spreading Profiles in South Korea, Italy and Iran by Data-Driven Coding |
|---|
|
The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice |
|---|
Risk Factors
|
Age-dependent risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China |
|---|
|
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
|---|
|
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy |
|---|
|
Cigarette smoke triggers the expansion of a subpopulation of respiratory epithelial cells that express the SARS-CoV-2 ... |
|---|
|
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study |
|---|
|
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence? |
|---|
|
COVID-19 patients often infected with other respiratory viruses, preliminary study reports |
|---|
|
Diabetes is a risk factor for the progression and prognosis of COVID-19 |
|---|
|
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 |
|---|
|
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease... |
|---|
|
Risk of COVID-19 for cancer patients |
|---|
|
SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes |
|---|
|
What are the risks of COVID-19 infection in pregnant women? |
|---|
Transmission
|
2019-nCoV transmission through the ocular surface must not be ignored |
|---|
|
A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person... |
|---|
|
Advances on presymptomatic or asymptomatic carrier transmission of COVID-19 |
|---|
|
Early dynamics of transmission and control of COVID-19: a mathematical modelling study |
|---|
|
Early Release - Indirect Virus Transmission in Cluster of COVID-19 Cases |
|---|
|
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia |
|---|
|
Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible? |
|---|
|
Epidemiology of Covid-19 in a Long-Term Care Facility in King County |
|---|
|
Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected... |
|---|
|
Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids |
|---|
|
The impact of transmission control measures during the first 50 days of the COVID-19 epidemic in China |
|---|
|
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status |
|---|
|
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany |
|---|